StonvexLoading…
StonvexStonvexStonvexCore line items from NEU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $669.72M | $2.73B | $2.09B | $1.40B |
Operating Income | $143.23M | $543.73M | $433.70M | $303.02M |
Net Income | $118.07M | $418.75M | $337.46M | $237.19M |
EPS (Diluted) | $12.62 | $44.44 | $35.78 | $25.11 |
Total Assets | $3.50B | $3.49B | $3.23B | $3.19B |
Total Liabilities | $1.77B | $1.71B | $1.54B | $1.58B |
Cash & Equivalents | $73.16M | $77.60M | $102.45M | $70.26M |
Free Cash Flow OCF − CapEx | $99.68M | $491.33M | $374.16M | $252.09M |
Shares Outstanding | 9.20M | 9.40M | 9.40M | 9.40M |